Efficacy and Safety of Topical Rapamycin in Patients With Facial Angiofibromas Secondary to Tuberous Sclerosis Complex: The TREATMENT Randomized Clinical Trial. [electronic resource]
Producer: 20190916Description: 773-780 p. digitalISSN:- 2168-6084
- Administration, Cutaneous
- Adolescent
- Adult
- Angiofibroma -- drug therapy
- Child
- Child, Preschool
- Double-Blind Method
- Facial Neoplasms -- drug therapy
- Female
- Humans
- Immunosuppressive Agents -- adverse effects
- Male
- Middle Aged
- Prospective Studies
- Quality of Life
- Severity of Illness Index
- Sirolimus -- adverse effects
- Skin Neoplasms -- drug therapy
- Time Factors
- Tuberous Sclerosis -- complications
- Young Adult
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.